Search results
Lung cancer: Pre- and postsurgical immunotherapy may improve outcomes
Medical News Today· 3 days agoLung cancer is a major cause of all cancer-related deaths, with some treatment options involving...
Why breast cancer recurrence rates are higher in Black women
Rolling Out· 4 days agoBreast cancer is a pervasive health concern that affects women globally, but its impact varies...
Breast cancer tissue kept alive for week outside the body in research breakthrough
Daily Telegraph· 4 days agoThis new approach means that we can start to determine which drugs will work for which women by...
Study investigates whether Weo electrolyzed water can modulate phenotype of senescent cells
Medical Xpress· 2 days agoA new research paper titled "Cell type-dependent modulation of senescence features using Weo electrolyzed water" has been published in Aging.
Logiq, Inc. Signs Letter of Intent to Acquire Privately Held Biotech Company MedLab Essentials, LLC...
Digital Journal· 13 hours agoNew factors emerge from time to time, and it is not possible for Logiq to predict all of them, or assess the impact of each such factor
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 13 hours agoPatients in the study...
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of...
Digital Journal· 12 hours agoINTASYL drugs precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. For ...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 22 hours agoEisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical Oncology ...
The Current State Of Skin Cancer
Women s Health· 18 hours agoThe American Academy of Dermatology also points out that the rates of melanoma in people under 50 are higher in women than in men. “The incidence of...
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
FOX 4 Kansas City· 13 hours agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical Oncology ...